Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial
Titel:
Oral ibandronic acid versus intravenous zoledronic acid in treatment of bone metastases from breast cancer: a randomised, open label, non-inferiority phase 3 trial
Auteur:
Barrett-Lee, Peter Casbard, Angela Abraham, Jacinta Hood, Kerenza Coleman, Robert Simmonds, Peter Timmins, Hayley Wheatley, Duncan Grieve, Robert Griffiths, Gareth Murray, Nick